Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories

PALO ALTO, Calif. & MINNEAPOLIS, Minn.–(BUSINESS WIRE)–GERO, a leading AI-driven biotechnology company focused on aging and longevity and FOXO Technologies Inc. (NYSEAM: FOXO), a leader in epigenetic biomarker discovery and commercialization, today announced the commencement of discussions to form a strategic collaboration between the two companies. As a result, FOXO…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks